Reckitt Benckiser
FDA warns three US infant-formula manufacturers over production methods
US regulator The Food and Drug Administration (FDA) has issued warning letters to three infant-formula manufacturers over their production processes…
Reckitt Benckiser insider Kris Licht to take top job
Reckitt Benckiser has named former health-division president Kris Licht as CEO following an eight-month search. Benckiser takes the baton from…
Reckitt recalls infant-formula in US in Cronobacter bacteria scare
Reckitt Benckiser has instigated a large-scale infant-formula recall in the US because of possible health risks linked to contamination from…
Laxman Narasimhan’s exit as Reckitt Benckiser CEO met with surprise
The scheduled departure of Reckitt Benckiser’s chief executive Laxman Narasimhan has confounded analysts. Narasimhan will step down as CEO of…
Reckitt Benckiser ‘may shelve plan to sell infant-nutrition unit’
UK consumer goods major Reckitt Benckiser is reportedly considering postponing plans to sell its infant-formula unit. News agency Bloomberg, quoting…
Bidders for Reckitt Benckiser’s infant-formula assets reportedly spooked by US shortage
Another private-equity name has reportedly popped up as a possible interested bidder in Reckitt Benckiser’s infant-formula business. Clayton Dubilier &…
Reckitt ‘starts process to sell infant-formula assets’
Reckitt Benckiser has reportedly kicked off plans to sell its remaining businesses in infant formula. The UK group, home to…
Reckitt Benckiser ‘ponders sale of infant-nutrition business’
UK consumer goods heavyweight Reckitt Benckiser is reportedly considering the future of its infant-nutrition business. Bloomberg, citing people familiar with…
Reckitt Benckiser sells China infant-formula business to Primavera Capital
Reckitt Benckiser has agreed a deal to sell its infant-formula operations in China to local investment firm Primavera Capital Group.…
Reckitt ‘draws up bidder shortlist for China infant-formula unit’
The UK-based FMCG group said in February it would be weighing up its options over its infant-formula operations in the…